< Banner Randomizer >
< === Background-color: Start (#00518b) === >
Improving patient access to cancer clinical trials nationwide.
< === Background-color: End === >
< News Brief >
About Our Programs
View summaries for our Lazarex CARE, IMPACT, and Cancer Wellness HUBs programs that provide clinical trial navigation, financial assistance, advocacy, outreach and community engagement.
FIND OUT MORE
Lazarex 5.44K 2024
Saturday, April 20, 2024: Join us for our 7th annual 5.44K run/walk fundraiser that you can do anywhere, in your hometown or at our gathering in Danville, CA. Register as an Individual, Join a Team, or Create a Team.
SIGN UP | LEARN MORE
Willis Watson Book
Willis Watson Is a Wannabe is a book that we hope will inspire young children of color to be the next generation of medical professionals. This is part of our advocacy efforts to advance equity and access in cancer care.
ORDER | LEARN MORE
< News Brief >
A Journey of Cancer and Faith
Tamra is a woman deeply committed to her faith and from the first moment she learned she had Stage 3 Melanoma, she worried less about how cancer will personally impact her and focused more on how she could use this experience to uplift others on a similar journey.
READ MORE
What We Do
At Lazarex Cancer Foundation we help identify FDA cancer clinical trial options, and reimburse out of pocket travel expenses for travel to cancer clinical trial treatments. We make lifesaving connections that give hope to patients now, and opportunity for new treatments in the future.
WATCH THE VIDEO
The State of Diversity in Cancer Clinical Trials 2024
The state of diversity in cancer clinical trials today reflects persistent inequities, with minority racial and ethnic groups being underrepresented. Efforts to improve diversity have faced challenges, including low participation rates among African American and Hispanic American individuals. It is crucial for industry sponsors to prioritize diversity and for Congress to extend mandates to all cancer clinical trials to address this issue effectively.
READ MORE
